カテゴリ： QYResearch, 世界, 医療/バイオ

ヒト組換え増殖因子の世界市場2025年：組換えヒト上皮成長因子、その他

■ 英語タイトル：Global Human Recombinant Growth Factors Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA2756）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA2756
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：消費財
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒト組換え増殖因子の世界市場2025年：組換えヒト上皮成長因子、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はヒト組換え増殖因子のグローバル市場について調査・分析し、世界のヒト組換え増殖因子市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（組換えヒト上皮成長因子、その他）、用途別セグメント分析（科学研究、工業生産）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnologyなどが含まれています。ヒト組換え増殖因子のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、ヒト組換え増殖因子市場規模を算出する際に考慮しました。

・ヒト組換え増殖因子市場の概要
- 製品の定義
- ヒト組換え増殖因子の種類別セグメント
- 世界のヒト組換え増殖因子市場規模：タイプ別分析（組換えヒト上皮成長因子、その他）
- ヒト組換え増殖因子の用途別セグメント
- 世界のヒト組換え増殖因子市場規模：用途別分析（科学研究、工業生産）
- 世界のヒト組換え増殖因子市場規模予測（2020年-2031年）
- ヒト組換え増殖因子の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ヒト組換え増殖因子市場の競争状況およびトレンド

・ヒト組換え増殖因子の地域別市場規模
- 北米のヒト組換え増殖因子市場規模（2020年-2031年）
- 米国のヒト組換え増殖因子市場規模（2020年-2031年）
- ヨーロッパのヒト組換え増殖因子市場規模（2020年-2031年）
- アジア太平洋のヒト組換え増殖因子市場規模（2020年-2031年）
- 中国のヒト組換え増殖因子市場規模（2020年-2031年）
- 日本のヒト組換え増殖因子市場規模（2020年-2031年）
- 韓国のヒト組換え増殖因子市場規模（2020年-2031年）
- インドのヒト組換え増殖因子市場規模（2020年-2031年）
- オーストラリアのヒト組換え増殖因子市場規模（2020年-2031年）
- 中南米のヒト組換え増殖因子市場規模（2020年-2031年）
- 中東・アフリカのヒト組換え増殖因子市場規模（2020年-2031年）

・種類別セグメント：組換えヒト上皮成長因子、その他
- 世界のヒト組換え増殖因子のタイプ別販売量（2020年-2025年）
- 世界のヒト組換え増殖因子のタイプ別売上（2020年-2025年）
- 世界のヒト組換え増殖因子のタイプ別価格

・用途別セグメント：科学研究、工業生産
- 世界のヒト組換え増殖因子の用途別販売量（2020年-2025年）
- 世界のヒト組換え増殖因子の用途別売上（2020年-2025年）
- 世界のヒト組換え増殖因子の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnology

・産業チェーンと販売チャネルの分析
- ヒト組換え増殖因子産業チェーン分析
- ヒト組換え増殖因子の主要原材料
- ヒト組換え増殖因子の販売チャネル
- ヒト組換え増殖因子のディストリビューター
- ヒト組換え増殖因子の主要顧客

・ヒト組換え増殖因子市場ダイナミクス
- ヒト組換え増殖因子の業界動向
- ヒト組換え増殖因子市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Human Recombinant Growth Factors market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Human Recombinant Growth Factors is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Recombinant Growth Factors is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Human Recombinant Growth Factors include Thermo Fisher, Irvine Scientific, Biologics International Corp, R&D Systems, BioLegend, Corning, VWR, CellGenix GmbH and Shenandoah Biotechnology, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Recombinant Growth Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Recombinant Growth Factors.
The Human Recombinant Growth Factors market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Recombinant Growth Factors market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Recombinant Growth Factors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Thermo Fisher
Irvine Scientific
Biologics International Corp
R&D Systems
BioLegend
Corning
VWR
CellGenix GmbH
Shenandoah Biotechnology
Segment by Type
Recombinant Human Epidermal Growth Factor
Other
Segment by Application
Scientific Research
Industrial Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Recombinant Growth Factors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Recombinant Growth Factors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Human Recombinant Growth Factors Market Overview
1.1 Product Overview and Scope of Human Recombinant Growth Factors
1.2 Human Recombinant Growth Factors Segment by Type
1.2.1 Global Human Recombinant Growth Factors Market Value Comparison by Type (2025-2031)
1.2.2 Recombinant Human Epidermal Growth Factor
1.2.3 Other
1.3 Human Recombinant Growth Factors Segment by Application
1.3.1 Global Human Recombinant Growth Factors Market Value by Application: (2025-2031)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Human Recombinant Growth Factors Market Size Estimates and Forecasts
1.4.1 Global Human Recombinant Growth Factors Revenue 2020-2031
1.4.2 Global Human Recombinant Growth Factors Sales 2020-2031
1.4.3 Global Human Recombinant Growth Factors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Recombinant Growth Factors Market Competition by Manufacturers
2.1 Global Human Recombinant Growth Factors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Recombinant Growth Factors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Recombinant Growth Factors Average Price by Manufacturers (2020-2025)
2.4 Global Human Recombinant Growth Factors Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Human Recombinant Growth Factors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Recombinant Growth Factors, Product Type & Application
2.7 Human Recombinant Growth Factors Market Competitive Situation and Trends
2.7.1 Human Recombinant Growth Factors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Recombinant Growth Factors Players Market Share by Revenue
2.7.3 Global Human Recombinant Growth Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Recombinant Growth Factors Retrospective Market Scenario by Region
3.1 Global Human Recombinant Growth Factors Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Human Recombinant Growth Factors Global Human Recombinant Growth Factors Sales by Region: 2020-2031
3.2.1 Global Human Recombinant Growth Factors Sales by Region: 2020-2025
3.2.2 Global Human Recombinant Growth Factors Sales by Region: 2026-2031
3.3 Global Human Recombinant Growth Factors Global Human Recombinant Growth Factors Revenue by Region: 2020-2031
3.3.1 Global Human Recombinant Growth Factors Revenue by Region: 2020-2025
3.3.2 Global Human Recombinant Growth Factors Revenue by Region: 2026-2031
3.4 North America Human Recombinant Growth Factors Market Facts & Figures by Country
3.4.1 North America Human Recombinant Growth Factors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Recombinant Growth Factors Sales by Country (2020-2031)
3.4.3 North America Human Recombinant Growth Factors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Recombinant Growth Factors Market Facts & Figures by Country
3.5.1 Europe Human Recombinant Growth Factors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Recombinant Growth Factors Sales by Country (2020-2031)
3.5.3 Europe Human Recombinant Growth Factors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Recombinant Growth Factors Market Facts & Figures by Country
3.6.1 Asia Pacific Human Recombinant Growth Factors Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Recombinant Growth Factors Sales by Country (2020-2031)
3.6.3 Asia Pacific Human Recombinant Growth Factors Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Recombinant Growth Factors Market Facts & Figures by Country
3.7.1 Latin America Human Recombinant Growth Factors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Recombinant Growth Factors Sales by Country (2020-2031)
3.7.3 Latin America Human Recombinant Growth Factors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Recombinant Growth Factors Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Recombinant Growth Factors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Recombinant Growth Factors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Recombinant Growth Factors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Recombinant Growth Factors Sales by Type (2020-2031)
4.1.1 Global Human Recombinant Growth Factors Sales by Type (2020-2025)
4.1.2 Global Human Recombinant Growth Factors Sales by Type (2026-2031)
4.1.3 Global Human Recombinant Growth Factors Sales Market Share by Type (2020-2031)
4.2 Global Human Recombinant Growth Factors Revenue by Type (2020-2031)
4.2.1 Global Human Recombinant Growth Factors Revenue by Type (2020-2025)
4.2.2 Global Human Recombinant Growth Factors Revenue by Type (2026-2031)
4.2.3 Global Human Recombinant Growth Factors Revenue Market Share by Type (2020-2031)
4.3 Global Human Recombinant Growth Factors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Recombinant Growth Factors Sales by Application (2020-2031)
5.1.1 Global Human Recombinant Growth Factors Sales by Application (2020-2025)
5.1.2 Global Human Recombinant Growth Factors Sales by Application (2026-2031)
5.1.3 Global Human Recombinant Growth Factors Sales Market Share by Application (2020-2031)
5.2 Global Human Recombinant Growth Factors Revenue by Application (2020-2031)
5.2.1 Global Human Recombinant Growth Factors Revenue by Application (2020-2025)
5.2.2 Global Human Recombinant Growth Factors Revenue by Application (2026-2031)
5.2.3 Global Human Recombinant Growth Factors Revenue Market Share by Application (2020-2031)
5.3 Global Human Recombinant Growth Factors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Human Recombinant Growth Factors Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Irvine Scientific
6.2.1 Irvine Scientific Corporation Information
6.2.2 Irvine Scientific Description and Business Overview
6.2.3 Irvine Scientific Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Irvine Scientific Human Recombinant Growth Factors Product Portfolio
6.2.5 Irvine Scientific Recent Developments/Updates
6.3 Biologics International Corp
6.3.1 Biologics International Corp Corporation Information
6.3.2 Biologics International Corp Description and Business Overview
6.3.3 Biologics International Corp Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biologics International Corp Human Recombinant Growth Factors Product Portfolio
6.3.5 Biologics International Corp Recent Developments/Updates
6.4 R&D Systems
6.4.1 R&D Systems Corporation Information
6.4.2 R&D Systems Description and Business Overview
6.4.3 R&D Systems Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 R&D Systems Human Recombinant Growth Factors Product Portfolio
6.4.5 R&D Systems Recent Developments/Updates
6.5 BioLegend
6.5.1 BioLegend Corporation Information
6.5.2 BioLegend Description and Business Overview
6.5.3 BioLegend Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioLegend Human Recombinant Growth Factors Product Portfolio
6.5.5 BioLegend Recent Developments/Updates
6.6 Corning
6.6.1 Corning Corporation Information
6.6.2 Corning Description and Business Overview
6.6.3 Corning Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Corning Human Recombinant Growth Factors Product Portfolio
6.6.5 Corning Recent Developments/Updates
6.7 VWR
6.6.1 VWR Corporation Information
6.6.2 VWR Description and Business Overview
6.6.3 VWR Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VWR Human Recombinant Growth Factors Product Portfolio
6.7.5 VWR Recent Developments/Updates
6.8 CellGenix GmbH
6.8.1 CellGenix GmbH Corporation Information
6.8.2 CellGenix GmbH Description and Business Overview
6.8.3 CellGenix GmbH Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CellGenix GmbH Human Recombinant Growth Factors Product Portfolio
6.8.5 CellGenix GmbH Recent Developments/Updates
6.9 Shenandoah Biotechnology
6.9.1 Shenandoah Biotechnology Corporation Information
6.9.2 Shenandoah Biotechnology Description and Business Overview
6.9.3 Shenandoah Biotechnology Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shenandoah Biotechnology Human Recombinant Growth Factors Product Portfolio
6.9.5 Shenandoah Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Recombinant Growth Factors Industry Chain Analysis
7.2 Human Recombinant Growth Factors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Recombinant Growth Factors Production Mode & Process
7.4 Human Recombinant Growth Factors Sales and Marketing
7.4.1 Human Recombinant Growth Factors Sales Channels
7.4.2 Human Recombinant Growth Factors Distributors
7.5 Human Recombinant Growth Factors Customers
8 Human Recombinant Growth Factors Market Dynamics
8.1 Human Recombinant Growth Factors Industry Trends
8.2 Human Recombinant Growth Factors Market Drivers
8.3 Human Recombinant Growth Factors Market Challenges
8.4 Human Recombinant Growth Factors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Human Recombinant Growth Factors Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Human Recombinant Growth Factors Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Human Recombinant Growth Factors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Recombinant Growth Factors Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Human Recombinant Growth Factors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Recombinant Growth Factors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Recombinant Growth Factors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Recombinant Growth Factors Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Recombinant Growth Factors, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Human Recombinant Growth Factors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Recombinant Growth Factors, Product Type & Application
Table 12. Global Key Manufacturers of Human Recombinant Growth Factors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Recombinant Growth Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Recombinant Growth Factors as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Recombinant Growth Factors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Recombinant Growth Factors Sales by Region (2020-2025) & (Kg)
Table 18. Global Human Recombinant Growth Factors Sales Market Share by Region (2020-2025)
Table 19. Global Human Recombinant Growth Factors Sales by Region (2026-2031) & (Kg)
Table 20. Global Human Recombinant Growth Factors Sales Market Share by Region (2026-2031)
Table 21. Global Human Recombinant Growth Factors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Recombinant Growth Factors Revenue Market Share by Region (2020-2025)
Table 23. Global Human Recombinant Growth Factors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Recombinant Growth Factors Revenue Market Share by Region (2026-2031)
Table 25. North America Human Recombinant Growth Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Recombinant Growth Factors Sales by Country (2020-2025) & (Kg)
Table 27. North America Human Recombinant Growth Factors Sales by Country (2026-2031) & (Kg)
Table 28. North America Human Recombinant Growth Factors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Recombinant Growth Factors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Recombinant Growth Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Recombinant Growth Factors Sales by Country (2020-2025) & (Kg)
Table 32. Europe Human Recombinant Growth Factors Sales by Country (2026-2031) & (Kg)
Table 33. Europe Human Recombinant Growth Factors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Recombinant Growth Factors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Recombinant Growth Factors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Recombinant Growth Factors Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Human Recombinant Growth Factors Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Human Recombinant Growth Factors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Recombinant Growth Factors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Recombinant Growth Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Recombinant Growth Factors Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Human Recombinant Growth Factors Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Human Recombinant Growth Factors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Recombinant Growth Factors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Human Recombinant Growth Factors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Human Recombinant Growth Factors Sales by Country (2020-2025) & (Kg)
Table 47. Middle East & Africa Human Recombinant Growth Factors Sales by Country (2026-2031) & (Kg)
Table 48. Middle East & Africa Human Recombinant Growth Factors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Human Recombinant Growth Factors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Recombinant Growth Factors Sales (Kg) by Type (2020-2025)
Table 51. Global Human Recombinant Growth Factors Sales (Kg) by Type (2026-2031)
Table 52. Global Human Recombinant Growth Factors Sales Market Share by Type (2020-2025)
Table 53. Global Human Recombinant Growth Factors Sales Market Share by Type (2026-2031)
Table 54. Global Human Recombinant Growth Factors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Recombinant Growth Factors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Recombinant Growth Factors Revenue Market Share by Type (2020-2025)
Table 57. Global Human Recombinant Growth Factors Revenue Market Share by Type (2026-2031)
Table 58. Global Human Recombinant Growth Factors Price (US$/Kg) by Type (2020-2025)
Table 59. Global Human Recombinant Growth Factors Price (US$/Kg) by Type (2026-2031)
Table 60. Global Human Recombinant Growth Factors Sales (Kg) by Application (2020-2025)
Table 61. Global Human Recombinant Growth Factors Sales (Kg) by Application (2026-2031)
Table 62. Global Human Recombinant Growth Factors Sales Market Share by Application (2020-2025)
Table 63. Global Human Recombinant Growth Factors Sales Market Share by Application (2026-2031)
Table 64. Global Human Recombinant Growth Factors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Recombinant Growth Factors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Recombinant Growth Factors Revenue Market Share by Application (2020-2025)
Table 67. Global Human Recombinant Growth Factors Revenue Market Share by Application (2026-2031)
Table 68. Global Human Recombinant Growth Factors Price (US$/Kg) by Application (2020-2025)
Table 69. Global Human Recombinant Growth Factors Price (US$/Kg) by Application (2026-2031)
Table 70. Thermo Fisher Corporation Information
Table 71. Thermo Fisher Description and Business Overview
Table 72. Thermo Fisher Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Human Recombinant Growth Factors Product
Table 74. Thermo Fisher Recent Developments/Updates
Table 75. Irvine Scientific Corporation Information
Table 76. Irvine Scientific Description and Business Overview
Table 77. Irvine Scientific Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Irvine Scientific Human Recombinant Growth Factors Product
Table 79. Irvine Scientific Recent Developments/Updates
Table 80. Biologics International Corp Corporation Information
Table 81. Biologics International Corp Description and Business Overview
Table 82. Biologics International Corp Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. Biologics International Corp Human Recombinant Growth Factors Product
Table 84. Biologics International Corp Recent Developments/Updates
Table 85. R&D Systems Corporation Information
Table 86. R&D Systems Description and Business Overview
Table 87. R&D Systems Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. R&D Systems Human Recombinant Growth Factors Product
Table 89. R&D Systems Recent Developments/Updates
Table 90. BioLegend Corporation Information
Table 91. BioLegend Description and Business Overview
Table 92. BioLegend Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. BioLegend Human Recombinant Growth Factors Product
Table 94. BioLegend Recent Developments/Updates
Table 95. Corning Corporation Information
Table 96. Corning Description and Business Overview
Table 97. Corning Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Corning Human Recombinant Growth Factors Product
Table 99. Corning Recent Developments/Updates
Table 100. VWR Corporation Information
Table 101. VWR Description and Business Overview
Table 102. VWR Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. VWR Human Recombinant Growth Factors Product
Table 104. VWR Recent Developments/Updates
Table 105. CellGenix GmbH Corporation Information
Table 106. CellGenix GmbH Description and Business Overview
Table 107. CellGenix GmbH Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. CellGenix GmbH Human Recombinant Growth Factors Product
Table 109. CellGenix GmbH Recent Developments/Updates
Table 110. Shenandoah Biotechnology Corporation Information
Table 111. Shenandoah Biotechnology Description and Business Overview
Table 112. Shenandoah Biotechnology Human Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Shenandoah Biotechnology Human Recombinant Growth Factors Product
Table 114. Shenandoah Biotechnology Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Recombinant Growth Factors Distributors List
Table 118. Human Recombinant Growth Factors Customers List
Table 119. Human Recombinant Growth Factors Market Trends
Table 120. Human Recombinant Growth Factors Market Drivers
Table 121. Human Recombinant Growth Factors Market Challenges
Table 122. Human Recombinant Growth Factors Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Recombinant Growth Factors
Figure 2. Global Human Recombinant Growth Factors Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Human Recombinant Growth Factors Market Share by Type in 2024 & 2031
Figure 4. Recombinant Human Epidermal Growth Factor Product Picture
Figure 5. Other Product Picture
Figure 6. Global Human Recombinant Growth Factors Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 7. Global Human Recombinant Growth Factors Market Share by Application in 2024 & 2031
Figure 8. Scientific Research
Figure 9. Industrial Production
Figure 10. Global Human Recombinant Growth Factors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Human Recombinant Growth Factors Market Size (2020-2031) & (US$ Million)
Figure 12. Global Human Recombinant Growth Factors Sales (2020-2031) & (Kg)
Figure 13. Global Human Recombinant Growth Factors Average Price (US$/Kg) & (2020-2031)
Figure 14. Human Recombinant Growth Factors Report Years Considered
Figure 15. Human Recombinant Growth Factors Sales Share by Manufacturers in 2024
Figure 16. Global Human Recombinant Growth Factors Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Human Recombinant Growth Factors Players: Market Share by Revenue in 2024
Figure 18. Human Recombinant Growth Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 19. Global Human Recombinant Growth Factors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Human Recombinant Growth Factors Sales Market Share by Country (2020-2031)
Figure 21. North America Human Recombinant Growth Factors Revenue Market Share by Country (2020-2031)
Figure 22. United States Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Human Recombinant Growth Factors Sales Market Share by Country (2020-2031)
Figure 25. Europe Human Recombinant Growth Factors Revenue Market Share by Country (2020-2031)
Figure 26. Germany Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Human Recombinant Growth Factors Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Human Recombinant Growth Factors Revenue Market Share by Region (2020-2031)
Figure 33. China Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Human Recombinant Growth Factors Sales Market Share by Country (2020-2031)
Figure 43. Latin America Human Recombinant Growth Factors Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Human Recombinant Growth Factors Sales Market Share by Country (2020-2031)
Figure 48. Middle East & Africa Human Recombinant Growth Factors Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Human Recombinant Growth Factors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Human Recombinant Growth Factors by Type (2020-2031)
Figure 53. Global Revenue Market Share of Human Recombinant Growth Factors by Type (2020-2031)
Figure 54. Global Human Recombinant Growth Factors Price (US$/Kg) by Type (2020-2031)
Figure 55. Global Sales Market Share of Human Recombinant Growth Factors by Application (2020-2031)
Figure 56. Global Revenue Market Share of Human Recombinant Growth Factors by Application (2020-2031)
Figure 57. Global Human Recombinant Growth Factors Price (US$/Kg) by Application (2020-2031)
Figure 58. Human Recombinant Growth Factors Value Chain
Figure 59. Human Recombinant Growth Factors Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

※参考情報

ヒト組換え増殖因子は、遺伝子組換え技術を用いて製造された成長因子であり、さまざまな生理的プロセスに関与しています。これらは主に細胞の成長、分化、増殖を調節する重要な役割を果たしています。ヒト組換え増殖因子は、主に医療の分野で利用され、特に再生医療、癌治療、自己免疫疾患の治療などにおいて、その重要性が高まっています。

まず、ヒト組換え増殖因子の定義には、遺伝子工学の技術を用いたものが含まれます。一般的には、特定の遺伝子が大腸菌や酵母、哺乳類細胞などの宿主細胞に導入され、これを基にして生理活性を持つタンパク質が合成されます。これにより、純度の高い増殖因子を大量に得ることが可能になります。このプロセスは、タンパク質の発現システムと言われ、さまざまな種類の宿主細胞が使用されます。

ヒト組換え増殖因子の特徴の一つは、その高い特異性と活性です。これらの因子は、特定の受容体に結合することで細胞内のシグナル伝達経路を活性化し、細胞の応答を引き起こします。また、自然に存在する増殖因子と同様に、生理的条件下で機能するように設計されています。さらに、ヒトから得られるため、抗原性が低く、副作用のリスクが軽減されるというメリットがあります。

種類としては、多様なヒト組換え増殖因子が存在します。例えば、ヒトエリスロポエチン（rhEPO）は、赤血球の生成を促進する因子であり、貧血の治療に使用されます。また、ヒトインスリンは、糖尿病患者の血糖値の管理に重要な役割を果たしています。その他にも、成長ホルモン（rhGH）や、トロンボポエチン（rhTPO）、神経栄養因子（NGF）などがあり、それぞれが異なる生理的機能を持っています。

用途に関しては、ヒト組換え増殖因子は多岐にわたります。医療分野では、慢性腎疾患や癌、自己免疫疾患などの治療に用いられることが一般的です。特に、血液の生成を促進する因子は、化学療法による副作用で白血球数が減少した患者に対して使用されます。また、成長ホルモンは、小児の成長障害や成人の成長ホルモン欠乏症に対して効果が認められています。さらに、神経栄養因子は、神経の保護や再生を促進するための研究が進められています。

関連技術としては、タンパク質工学や合成生物学が挙げられます。これらの分野は、組換え技術の進化に寄与し、より精密に機能するタンパク質の設計や合成を可能にしています。また、バイオマーカーの発見や細胞療法、遺伝子編集技術といった新しいアプローチも、ヒト組換え増殖因子の利用範囲を広げています。特に、CRISPR技術を用いた遺伝子編集は、特定の疾患に対するターゲット治療の可能性を広げる上で重要な役割を果たしています。

最後に、ヒト組換え増殖因子の開発と応用には、倫理的な観点も重要です。クローン技術や遺伝子操作が進む中で、ヒトに適用する際には慎重なアプローチが求められます。医療における利点とリスクを十分に考慮し、安全かつ効果的な治療法としての確立を目指すことが必要でしょう。

このように、ヒト組換え増殖因子は、医療分野での多様な応用が期待される重要な技術であり、今後の研究や技術の進歩により、より高い効果が期待されています。私たちの健康と幸福に寄与するこれらの因子は、引き続き注目されるテーマであり、さらなる理解と研究が求められています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射用組換えヒトインターフェロンα2aの世界市場2025年：100万IU、300万IU、500万IU、その他
  • 組換えヒト顆粒球コロニー刺激因子注射（rhG-CSF）の世界市場2025年：バイアル、プレフィルド
  • 組換えヒト血清アルブミンの世界市場2025-2031：OsrHSA、ScrHSA
  • サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の世界市場2025年：25ml、50ml、100ml
  • 非動物性組換えタンパク質の世界市場2025-2031：前臨床用タンパク質、GMP用タンパク質
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA2756 )"ヒト組換え増殖因子の世界市場2025年：組換えヒト上皮成長因子、その他" (英文：Global Human Recombinant Growth Factors Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。